Federation des caisses Desjardins du Quebec’s Accelerate Diagnostics AXDX Stock Holding History
Bought
Maintained
Sold
Other funds holding AXDX
OIM
BC
CC
CS
GAM
CC
Federation des caisses Desjardins du Quebec's AXDX Position: Q3 2020 in Review
Federation des caisses Desjardins du Quebec sold out of Accelerate Diagnostics (AXDX) in Q3 2020, closing a stake of 10 shares — an estimated $1.52K sold.
Federation des caisses Desjardins du Quebec first reported a position in AXDX in Q1 2017 and held it in 14 quarters. The position peaked at $2.73K in Q2 2017. 112 funds tracked by Wall St. Rank hold AXDX as of Q3 2020.
- Federation des caisses Desjardins du Quebec reported no remaining Accelerate Diagnostics position as of Q3 2020 after selling out during the quarter.
- Federation des caisses Desjardins du Quebec sold 10 Accelerate Diagnostics shares in Q3 2020, an estimated $1.52K.
- Federation des caisses Desjardins du Quebec first reported a position in Accelerate Diagnostics in Q1 2017 and held it in 14 quarters.
- Federation des caisses Desjardins du Quebec's Accelerate Diagnostics position peaked at $2.73K in Q2 2017.
- 112 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q3 2020.
Based on Federation des caisses Desjardins du Quebec's 13F filing for Q3 2020, filed 30 Aug 2024.